Search Page

1

Cite

Share

Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.

Saravolatz LD, Depcinski S, Sharma M. Saravolatz LD, et al. Clin Infect Dis. 2022 Mar 4:ciac180. doi: 10.1093/cid/ciac180. Online ahead of print. Clin Infect Dis. 2022. PMID: 35245942

Cite

Share

2

Cite

Share

Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.

Premikha M, Chiew CJ, Wei WE, Leo YS, Ong B, Lye DC, Lee VJ, Tan KB. Premikha M, et al. Clin Infect Dis. 2022 Apr 12:ciac288. doi: 10.1093/cid/ciac288. Online ahead of print. Clin Infect Dis. 2022. PMID: 35412612 Free PMC article.

Cite

Share

3

Cite

Share

Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.

Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, Goldstein LH, Saliba W. Najjar-Debbiny R, et al. Clin Infect Dis. 2022 Jun 2:ciac443. doi: 10.1093/cid/ciac443. Online ahead of print. Clin Infect Dis. 2022. PMID: 35653428 Free PMC article.

Cite

Share

4

Cite

Share

SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.

Gazit S, Shlezinger R, Perez G, Lotan R, Peretz A, Ben-Tov A, Herzel E, Alapi H, Cohen D, Muhsen K, Chodick G, Patalon T. Gazit S, et al. Clin Infect Dis. 2022 Apr 5:ciac262. doi: 10.1093/cid/ciac262. Online ahead of print. Clin Infect Dis. 2022. PMID: 35380632 Free PMC article.

Cite

Share

5

Cite

Share

Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.

Ranganath N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, Pike ML, Michael O'Brien R, Razonable RR, Shah A. Ranganath N, et al. Clin Infect Dis. 2022 Jun 14:ciac481. doi: 10.1093/cid/ciac481. Online ahead of print. Clin Infect Dis. 2022. PMID: 35698452

Cite

Share

6

Cite

Share

BK Polyomavirus.

Hirsch HH, Mengel M, Kamar N. Hirsch HH, et al. Clin Infect Dis. 2022 Jul 20:ciac594. doi: 10.1093/cid/ciac594. Online ahead of print. Clin Infect Dis. 2022. PMID: 35856634 No abstract available.

Cite

Share

7

Cite

Share

Cover image/text.

Stuckey M. Stuckey M. Clin Infect Dis. 2022 Jul 7:ciac564. doi: 10.1093/cid/ciac564. Online ahead of print. Clin Infect Dis. 2022. PMID: 35797163 No abstract available.

Cite

Share

8

Cite

Share

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.

Li C, Ye Z, Zhang AJ, Chan JF, Song W, Liu F, Chen Y, Kwan MY, Lee AC, Zhao Y, Wong BH, Yip CC, Cai JP, Lung DC, Sridhar S, Jin D, Chu H, To KK, Yuen KY. Li C, et al. Clin Infect Dis. 2022 Feb 18:ciac142. doi: 10.1093/cid/ciac142. Online ahead of print. Clin Infect Dis. 2022. PMID: 35178548 Free PMC article.

Cite

Share

9

Cite

Share

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Tamma PD, et al. Clin Infect Dis. 2022 Apr 19:ciac268. doi: 10.1093/cid/ciac268. Online ahead of print. Clin Infect Dis. 2022. PMID: 35439291

Cite

Share

10

Cite

Share

Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak.

Cheng VC, Ip JD, Chu AW, Tam AR, Chan WM, Abdullah SMU, Chan BP, Wong SC, Kwan MY, Chua GT, Ip P, Chan JM, Lam BH, To WK, Chuang VW, Yuen KY, Hung IF, To KK. Cheng VC, et al. Clin Infect Dis. 2022 Mar 10:ciac203. doi: 10.1093/cid/ciac203. Online ahead of print. Clin Infect Dis. 2022. PMID: 35271728 Free PMC article.

Cite

Share